Terns Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Terns Pharmaceuticals's estimated annual revenue is currently $8.4M per year.
- Terns Pharmaceuticals's estimated revenue per employee is $104,222
- Terns Pharmaceuticals's current valuation is $145.3M. (January 2022)
Employee Data
- Terns Pharmaceuticals has 81 Employees.
- Terns Pharmaceuticals grew their employee count by 33% last year.
Terns Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Operating Officer & General Counsel | Reveal Email/Phone |
3 | Chief Business Officer | Reveal Email/Phone |
4 | VP, Program and Alliance Management | Reveal Email/Phone |
5 | VP, Business Development | Reveal Email/Phone |
6 | SVP, Medical Affairs | Reveal Email/Phone |
7 | SVP, Research | Reveal Email/Phone |
8 | SVP | Reveal Email/Phone |
9 | VP, Pharmaceutical Development | Reveal Email/Phone |
10 | Associate Director, Nonclinical Development | Reveal Email/Phone |
Terns Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Terns Pharmaceuticals?
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single- agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns' programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients.
keywords:N/A
N/A
Total Funding
81
Number of Employees
$8.4M
Revenue (est)
33%
Employee Growth %
$145.3M
Valuation
N/A
Accelerator
Terns Pharmaceuticals News
So we hope that those who held Terns Pharmaceuticals, Inc. (NASDAQ:TERN) during the last year don't lose the lesson, in addition to the 87% hit...
FOSTER CITY, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (Terns or the Company) (Nasdaq: TERN),...
Terns Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference. by Globe Newswire. April 4, 2022 4:05 PM | 1 min read.
Other Companies in Foster City
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 82 | 55% | N/A |
#2 | $12.9M | 83 | 0% | N/A |
#3 | $1.7M | 87 | 4% | N/A |
#4 | $17.7M | 87 | N/A | N/A |
#5 | $23.1M | 92 | 67% | N/A |